NEW YORK, NY / ACCESSWIRE / November 8, 2017 / U.S. markets retreated from their record highs Tuesday on mixed earnings and falling bond yields. The Dow Jones Industrial Average gained 0.04 percent to close at 23,557.23, while the S&P 500 Index fell 0.02 percent to close at 2,590.64. The NASDAQ Composite Index dropped 0.27 percent to close at 6,767.78. Financial stocks were hit the hardest Tuesday as the Financial Select Sector SPDR Fund declined 1.38 percent. The yield on the benchmark 10-year Treasury note dropped to 2.309 percent, from 2.318 percent Monday.

RDI Initiates Coverage on:

Celldex Therapeutics, Inc.
https://rdinvesting.com/news/?ticker=CLDX

Idera Pharmaceuticals, Inc.
https://rdinvesting.com/news/?ticker=IDRA

Celldex Therapeutics' stock gained 10.08% Tuesday, to close the day at $2.62. The stock recorded a trading volume of 2,707,704 shares, which was above its three months average volume of 1,451,490 shares. In the last year, Celldex Therapeutics shares have traded in a range of 2.20 - 5.02. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $2.78 is greater than its 200-day moving average of $2.69. Shares of Celldex Therapeutics have fallen roughly 17.09 percent in the past month and are down 25.99 percent year-to-date.

Access RDI's Celldex Therapeutics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=CLDX

On Tuesday, shares of Idera Pharmaceuticals, Inc. recorded a trading volume of 3,787,017 shares, which was above the three months average volume of 1,892,280 shares. The stock ended the day 3.31% higher at 1.87. The share price has gained 43.85% from its 52-week low with a 52-week trading range of 1.30 - 2.87.The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $2.19 is greater than its 200-day moving average of $1.94. Shares of Idera Pharmaceuticals have fallen roughly 23.05 percent in the past month and are up 24.67 percent year-to-date.

Access RDI's Idera Pharmaceuticals, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=IDRA

Our Actionable Research on Celldex Therapeutics, Inc. (NASDAQ: CLDX) and Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com